跳至主要内容
临床试验/NCT02953834
NCT02953834已完成1 期

Kisspeptin Influence on Glucose Homeostasis

Stephanie B. Seminara, MD1 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2017年7月18日最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
35
试验地点
1
主要终点
Average difference in area under the curve of insulin in response to a mixed meal tolerance test

研究概览

简要总结

The goal of this study is to learn about how a naturally occurring hormone called kisspeptin affects blood sugar and insulin levels.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • normal pubertal development
  • stable weight for previous three months
  • no active illicit drug use,
  • no history of a medication reaction requiring emergency medical care,
  • no difficulty with blood draws.
  • Physical examination:
  • systolic BP < 140 mm Hg, diastolic < 90 mm Hg,
  • Laboratory studies: (per MGH reference ranges)
  • normal hemoglobin, unless hypogonadal then no lower than 0.5 gm/dL below the lower limit of the reference range for normal women (as men and women with hypogonadism have lower hemoglobin levels off of treatment)
  • hemoglobin A1C < 6.5%
  • BUN, creatinine not elevated
  • AST, ALT < 3x upper limit of normal
  • negative serum pregnancy test (for all women)
  • no hyperlipidemia by fasting lipid panel
  • Additional Criteria by Study Population
  • Healthy Men:
  • normal body mass index (BMI between 18.5-25)
  • no history of chronic disease, except well controlled thyroid disease
  • no recent use of prescription medications which interfere with metabolism or reproduction. Use of levothyroxine or seasonal allergy medications is acceptable.
  • no history of diabetes in a first degree relative.
  • Healthy Women:
  • normal body mass index (BMI between 18.5-25)
  • no history of chronic disease, except well controlled thyroid disease,
  • no recent use of prescription medications which interfere with metabolism or reproduction. Use of levothyroxine or seasonal allergy medications is acceptable.
  • no history of diabetes in a first degree relative,
  • no use of contraceptive pills, patches or vaginal rings within last 4 weeks.
  • regular menstrual cycles
  • Postmenopausal Women:
  • body mass index (BMI between 18.5-30)
  • no history of chronic disease except thyroid disease, and osteoporosis,
  • no recent use of prescription medications which interfere with metabolism or reproduction. Use of levothyroxine, osteoporosis medications or seasonal allergy medications is acceptable,
  • no history of diabetes in a first degree relative,
  • normal activate protein C resistance screen,
  • if applicable, able to undergo appropriate washout from hormone therapy.
  • Men and Women with Impaired Glucose Tolerance (IGT):
  • diagnosis of impaired glucose tolerance by oral glucose tolerance test,
  • all medical conditions well-controlled.
  • Men and Women with Hypogonadism
  • diagnosis of hypogonadism,
  • all other medical conditions well-controlled,
  • if applicable, able to undergo appropriate washout from hormone therapy.

研究组 & 干预措施

Kisspeptin and Insulin Resistance Test

Experimental

Intravenous (IV) administration of kisspeptin 112-121; eat a standard mixed meal or drink a standard mixed meal or 75 grams of oral glucose

干预措施: kisspeptin 112-121 (Drug)

Kisspeptin and Insulin Resistance Test

Experimental

Intravenous (IV) administration of kisspeptin 112-121; eat a standard mixed meal or drink a standard mixed meal or 75 grams of oral glucose

干预措施: Insulin Resistance Test (Other)

Placebo and Insulin Resistance Test

Placebo Comparator

IV administration of fluids that contain no study drug; eat a standard mixed meal or drink a standard mixed meal or 75 grams of oral glucose

干预措施: Insulin Resistance Test (Other)

Placebo and Insulin Resistance Test

Placebo Comparator

IV administration of fluids that contain no study drug; eat a standard mixed meal or drink a standard mixed meal or 75 grams of oral glucose

干预措施: Placebo (Other)

结局指标

主要结局

Average difference in area under the curve of insulin in response to a mixed meal tolerance test

时间窗: 4 hours

Compares difference on and off kisspeptin

次要结局

  • Average difference in area under the curve of glucose in response to a mixed meal tolerance test(4 hours)
  • Average difference in area under the curve of glucagon-like peptide 1 in response to a mixed meal tolerance test(4 hours)

研究者

发起方
Stephanie B. Seminara, MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Stephanie B. Seminara, MD

Chief, Reproductive Endocrine Unit; Professor of Medicine, Harvard Medical School; Director, MGH Harvard Center for Reproductive Medicine

Massachusetts General Hospital

研究点 (1)

Loading locations...

相似试验